AstraZeneca Kft., secures contract for Pharmaceutical Products - Delivery of a medicinal product containing Palivizumab, used in the B40 drug program - prevention of infections with RS virus - for the Upper Silesian Children's Health Center.

Poland, April 3 -- Poland based AstraZeneca Kft., has secured contract from GORNOSLASKIE CENTRUM ZDROWIA DZIECKA im. sw. JANA PAWLA II Samodzielny Publiczny Szpital Kliniczny Nr 6 Slaskiego Uniwersytetu Medycznego w Katowicach for Pharmaceutical Products - Delivery of a medicinal product containing Palivizumab, used in the B40 drug program - prevention of infections with RS virus - for the Upper Silesian Children's Health Center.. The value of the contract is worth 149408640 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....